May 9 |
CorMedix GAAP EPS of -$0.25
|
May 9 |
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
|
May 6 |
CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024
|
Apr 19 |
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
|
Apr 11 |
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference
|
Apr 8 |
CorMedix enters into 5-year agreement with ARC Dialysis
|
Apr 8 |
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC
|
Apr 2 |
Breakeven On The Horizon For CorMedix Inc. (NASDAQ:CRMD)
|